A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
מצבים רפואיים
mCRPC (Metastatic Castration-resistant Prostate Cancer) · Prostate Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
MemorialCare Orange Coast Medical Center, Fountain Valley, California, United States
Contact: Principal Investigator (Amol Rao, MD)Cancer and Blood Research Center, Los Alamitos, California, United States
Contact: Principal Investigator (Collin Vu, MD)University of Colorado Health, Aurora, Colorado, United States
Contact: Principal Investigator (Elaine Lam, MD)Mount Sinai Medical Center, Miami, Florida, United States
Contact: Principal Investigator (Bruno Bastos, MD)Emory University Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Jordan Ciuro)University of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Mohammad Atiq, MD) · cancerclinicaltrials@bsd.uchicago.edu · 773-834-7002Contact: Principal Investigator (Mohammad Atiq)Community Health Network, Indianapolis, Indiana, United States
Contact: Principal Investigator (Natraj Ammakkanavar)Ochsner, Jefferson, Louisiana, United States
Contact: Principal Investigator (Brian Halbert)Johns Hopkins Hospital, Baltimore, Maryland, United States
Contact: Principal Investigator (Adel Mandl)Karmanos Cancer Institute, Detroit, Michigan, United States
Contact: Principal Investigator (Frank Cackowski, MD)Siteman Cancer Center, St Louis, Missouri, United States
Contact: Principal Investigator (Melissa Reimers, MD)Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Principal Investigator (Ralph Hauke, MD)Duke University medical center, Durham, North Carolina, United States
Contact: Principal Investigator (Andrew Armstrong, MD)The Ohio State University, Columbus, Ohio, United States
Contact: Principal Investigator (Lingbin Meng)Taylor Cancer Research Center, Maumee, Ohio, United States
Contact: Principal Investigator (John Nemunaitis)University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Tian Zhang, MD)Oncology Consultants, P.A, Houston, Texas, United States
Contact: Principal Investigator (Julio Peguero, MD)NEXT Oncology - Virginia, Fairfax, Virginia, United States
Contact: Principal Investigator (Mohamad Salkeni, MD)